Gainers
- Tricida, Inc. TCDA rose 37.7% to $0.1898 in pre-market trading after gaining 4% on Wednesday.
- Huadi International Group Co., Ltd. HUDI rose 26.7% to $7.16 in pre-market trading after gaining over 3% on Wednesday.
- Starbox Group Holdings Ltd. STBX shares rose 22.1% to $3.65 in pre-market trading after the company reported a rise in FY22 earnings.
- AIM ImmunoTech Inc. AIM shares rose 15.8% to $0.73 in pre-market trading after dropping 18% on Wednesday. AIM ImmunoTech recently entered into a sponsored collaborative clinical research agreement with Erasmus MC and AstraZeneca.
- Zymeworks Inc. ZYME rose 12% to $11.20 in pre-market trading.
- Berkshire Grey, Inc. BGRY shares rose 11.3% to $0.97 in pre-market trading after dropping 14% on Wednesday.
- TransCode Therapeutics, Inc. RNAZ rose 11% to $0.7680 in pre-market trading after jumping 15% on Wednesday. TransCode Therapeutics recently announced it received written authorization from the FDA that it may proceed with its First-in-Human Phase 0 clinical trial.
- BiondVax Pharmaceuticals Ltd. BVXV rose 9.1% to $3.02 in pre-market trading after dropping 10% on Wednesday. BiondVax recently announced additional results from preclinical study showing SARS-COV-2 presence of in hamsters treated with BiondVax's NanoAb was below detectable levels.
- CureVac N.V. CVAC rose 8.4% to $10.28 in pre-market trading. UBS upgraded CureVac from Neutral to Buy and announced an $18 price target.
- Humanigen, Inc. HGEN rose 6.5% to $0.1683 in pre-market trading after dropping around 5% on Wednesday.
Losers
- Ontrak, Inc. OTRK fell 12.8% to $0.9762 in pre-market trading. Ontrak shares jumped 95% on Wednesday after the company announced new data showing a reduction in depression and anxiety symptoms for Ontrak Health's Wholehealth+ program members.
- Sigilon Therapeutics, Inc. SGTX shares fell 14.2% to $0.4712 in pre-market trading. Sigilon Therapeutics shares jumped 33% on Wednesday after Canaccord Genuity initiated coverage on the stock with a Buy rating and a $6 price target.
- Olink Holding AB OLK shares fell 11.3% to $21.34 in pre-market trading after the company announced pricing of public offering of 5,831,028 American Depositary Shares at a price of $20 per ADS.
- Deciphera Pharmaceuticals, Inc. DCPH fell 10% to $18.55 in pre-market trading after the company reported a $125 million proposed public offering of common stock.
- TC Biopharm (Holdings) Plc TCBP fell 9.5% to $5.70 in pre-market trading after gaining around 28% on Wednesday. TC BioPharm recently announced a strategic collaboration to advance gamma-delta T cells in oncology.
- Magic Empire Global Limited MEGL fell 9.2% to $2.75 in pre-market trading after jumping 44% on Wednesday.
- ZyVersa Therapeutics, Inc. ZVSA shares fell 8.2% to $2.36 in pre-market trading after dropping over 15% on Wednesday.
- Veris Residential, Inc. VRE fell 8.1% to $14.95 in pre-market after the company outlined path to unlocking shareholder value.
- Vapotherm, Inc. VAPO shares dropped 7.1% to $1.45 in pre-market trading after dropping 14% on Wednesday.
- Alcoa Corporation AA fell 6.5% to $49.96 in pre-market trading after the company reported quarterly results and issued weak guidance.
Loading...
Loading...
AAAlcoa Corp
$31.30-0.69%
Edge Rankings
Momentum
17.96
Growth
88.66
Quality
Not Available
Value
93.05
Price Trend
Short
Medium
Long
AIMAIM ImmunoTech Inc
Not Available-%
CVACCureVac NV
$5.39-0.19%
HUDIHuadi International Group Co Ltd
$1.30-%
MEGLMagic Empire Global Ltd
$1.58-1.86%
OTRKOntrak Inc
$0.4755-1.55%
RNAZTransCode Therapeutics Inc
$8.603.77%
VAPOVapotherm Inc
$2.14116.2%
VREVeris Residential Inc
$14.720.41%
ZVSAZyVersa Therapeutics Inc
$0.6706-4.20%
ZYMEZymeworks Inc
$13.041.16%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.